Ferras Alwan

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura

Ferras Alwan, Chiara Vendramin, Karen Vanhoorelbeke et al. · Blood · 2017 · 126 citations · Full text

Medicine, Hematology, Pathology +12

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens

John‐Paul Westwood, Mari Thomas, Ferras Alwan et al. · Blood Advances · 2017 · 122 citations · Full text

Medicine, Hematology, Immunology +14

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Ferras Alwan, Annie He, Silvia Montoto et al. · AIDS · 2015 · 38 citations

Medicine, Oncology, Pharmacology +14

Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura

Ferras Alwan, Dina Mahdi, Lisa Cipolotti et al. · British Journal of Haematology · 2020 · 34 citations · Full text

Medicine, Hematology, Neurology +14

Plasma exchange for COVID‐19 thrombo‐inflammatory disease

Nishkantha Arulkumaran, Mari Thomas, David Brealey et al. · eJHaem · 2020 · 31 citations · Full text

Medicine, Hematology, Immunology +17